期刊文献+

2种剂型甲芬那酸制剂微生物限度与控制菌方法的比较 被引量:6

Verification of microbial limit and control bacteria tests for mefenamic acid in two kinds of dosage forms
下载PDF
导出
摘要 目的建立甲芬那酸胶囊与分散片剂微生物限度与控制菌的检查方法。方法采用常规法、培养基稀释法、薄膜过滤与加中和剂法对2种剂型甲芬那酸制剂进行微生物限度方法验证,采用直接接种法进行控制菌方法验证。结果甲芬那酸胶囊与分散剂均采用薄膜过滤与加中和剂法(稀释剂含100mL.L-1吐温80,冲洗量为600mL/膜)测定细菌数;常规法测定霉菌及酵母菌数;直接接种法进行大肠埃希菌检测。结论建立了2种剂型甲芬那酸制剂的微生物限度与控制菌检查方法。 Objective To estabilish mothods of the microbial limit and control bacteria tests for mefenamic acid capsules and dispersible tablets.Methods Routine method,medium diluting method,membrane filter and neutralization agent method were adopted for the verification of microbial methodology,and direct inoculation method for the control bacteria.Results Membrane filter and neutralization agent method were used for the bacterial count of mefenamic acid capsules and dispersible tablets,in which the diluent contained 100 mL·L-1 Twain 80 and the volume of washing fluid for each membrane was 600 mL.Routine method was used for yeast and mold count.The direct inoculation method was used for Escherichia coli.Conclusion The methods of the microbial limit and control bacteria tests for mefenamic acid capsules and dispersible tablets were established.
出处 《西北药学杂志》 CAS 2012年第6期576-578,共3页 Northwest Pharmaceutical Journal
关键词 甲芬那酸 胶囊 分散片剂 微生物限度方法验证 控制菌方法验证 mefenamic acid capsule dispersible tablets verification of microbial limit methodology verification of control bacteria methodology
  • 相关文献

参考文献7

  • 1沈芸荪,孙仁同,陈统辉.上海药物实用手册[M].上海:文汇出版社,1992:339.
  • 2Lira-Plaseeneia J,Alzola-Pnaiagua A,Carranza-Liar S.Fenoverine vs.mefenmaic acid in the treatment of prima-ry dysmenohrreal[J].Int J Gynaeeol Obstet,2006,93(1):72-83.
  • 3AL-Waili NS.Treatment of menstrual migraine with pros-tagland in synthesis inhibitor mefenamic acid:double-blindstudy with placebo[J].Eur J Med Res,2000,5(4):176-182.
  • 4JooY,Kim HS,Woo RS,et al.Mefenamic acid shows neuroprotective effects and improves cognitive impairment in vitroand in vivo Alzheimer's disease models[J].Mol Pharmacol2006,69(1):76-84.
  • 5国家药典委员会.中国药典([S].二部.北京:中国医药科技出版社,2010:附录107-116.
  • 6温玉莹,李汶,陈之敏.微生物验证试验中枯草芽孢杆菌菌悬液制备的探讨[J].今日药学,2009,19(5):69-70. 被引量:9
  • 7李秋菲,周志云,段润红.阿奇霉素分散片微生物限度检查法的建立与标准操作探讨[J].西北药学杂志,2008,23(6):384-386. 被引量:3

二级参考文献5

  • 1中华人民共和国药典委员会.中国药典.2005版第二部.北京:化学工业出版社,2005.附录93.
  • 2中华人民共和国药典委员会.中国药典.2005版第一部.北京:化学工业出版社,2005.183,549.
  • 3张治锬.抗生素药品检验.北京:人民卫生出版社,1991.29.
  • 4中国药典2005年版[S].二部.2005.261.
  • 5由亚宁,任安民,裴为芝.药品微生物验证枯草芽孢杆菌实验菌液制备方法的探讨[J].西北药学杂志,2007,22(6):345-345. 被引量:8

共引文献10

同被引文献41

  • 1光新兰,张洪,戴鹏飞.薄膜过滤法在药品检验中的应用[J].医药导报,2006,25(3):253-254. 被引量:24
  • 2向东,范兵,李红缨.薄膜过滤法检查蜂胶牙泰喷雾剂中微生物的限度[J].华西药学杂志,2006,21(3):299-300. 被引量:7
  • 3中国药典.二部[S].2010:凡例ⅩⅦ.
  • 4中华人民共和国国家药典委员会.中华人民共和国药典(一部)[M].北京:化学工业出版社,2005.279.
  • 5国家药品生物制品鉴定所.中国药品检验标准操作规范2010年版[M].北京:中国医药科技出版社,2010:356-358.
  • 6苏德模.最新药品微生物检验分析实用手册[M].北京:中国医药科技出版社,2012:183-185.
  • 7陈岩松.影响药品微生物限度检验的因素分析[J].健康必读(中旬刊),2012,11(12):136.
  • 8朱智峰.美洛昔康微生物限度检查方法的验证[N].江苏经济报,2010-07.17(B04).
  • 9WU L S, LIANG L J. Operation Specification for Drug Inspection [M]. Beijing: People's Military Medical Publisher, 2012: 320-333.
  • 10Pharmaceutics Regulates of Hospitals in Tianjin (2008) [S]. 2008: 505-506.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部